Menu

Health Canada Issues Safety Warning on IVC Filters, Baron & Budd Reports

Agency Recommends Healthcare Professionals Carefully Consider Risks of Device Before Implanting it in Patients DALLAS (July 28, 2016) – On July 25, 2016, Health Canada issued a safety warning regarding the risks of inferior vena [...]

July 28th, 2016|Pharmaceuticals|

Antipsychotic Drug Abilify Linked to Compulsive Gambling, Baron & Budd Reports

Patients May Be at Risk of Substantial Economic Losses, Psychological Distress DALLAS (June 20, 2016) – Several studies have linked the antipsychotic medication Abilify to the development of compulsive gambling in patients taking the drug, [...]

June 21st, 2016|Pharmaceuticals|

Fluoroquinolone Antibiotics Linked to Potentially Life-Threatening Aortic Injuries, Baron & Budd Reports

Studies Associate Aortic Aneurysms, Dissections With Medications Such as Avelox, Cipro and Levaquin DALLAS (June 1, 2016) – Patients taking powerful fluoroquinolone antibiotics such as Avelox, Cipro and Levaquin may be at a significantly higher [...]

June 1st, 2016|Pharmaceuticals|

Baron & Budd Accepting Cases Involving Complications Linked to Proton Pump Inhibitor Medications

Prevacid, Nexium, Prilosec, Others Linked to Kidney Disease and Kidney Failure DALLAS (May 6, 2016) – The national law firm of Baron & Budd is now accepting cases from clients who have suffered health complications [...]

May 6th, 2016|Pharmaceuticals|

Russell Budd of Baron & Budd Selected to Serve as Co-Lead Counsel for Fluoroquinolone Products Liability Litigation Executive Steering Committee

Budd to Help Oversee All Aspects of Multidistrict Litigation DALLAS (April 11, 2016) – The national law firm of Baron & Budd proudly announces that president and managing shareholder Russell Budd has been selected co-lead [...]

April 11th, 2016|Pharmaceuticals|

Baron & Budd Investigating Claims Involving the Alere INRatio Blood-Testing System

Device Linked to Serious Health Problems Due to Erroneous Results DALLAS (March 24, 2016) – The national law firm of Baron & Budd is investigating a potential class action lawsuit regarding the Alere INRatio blood-testing [...]

March 24th, 2016|Pharmaceuticals|

Baron & Budd Investigating Potential Litigation Involving Essure Permanent Birth Control Device

Essure Linked to Serious Health Complications in Women DALLAS (Feb. 2, 2016) – The national law firm of Baron & Budd is investigating potential legal action against Bayer AG, the manufacturer of the Essure permanent [...]

February 2nd, 2016|Pharmaceuticals|

Baron & Budd Investigating Potential Lawsuits Involving Onglyza

Drug Used to Treat Type 2 Diabetes Linked to Cancer, Heart Failure and Other Complications DALLAS (November 17, 2015) – The national law firm of Baron & Budd is investigating the possibility of legal action [...]

November 17th, 2015|Pharmaceuticals|

Baron & Budd Observes World Diabetes Day

National Law Firm Marks Occasion by Raising Awareness of Potentially Dangerous Diabetes Medications  DALLAS (Nov. 13, 2015) – The national law firm of Baron & Budd is marking World Diabetes Day, and also working to [...]

November 13th, 2015|News & Press Releases, Pharmaceuticals|

Baron & Budd Investigating Potential Lawsuits Involving Diabetes Drug Invokana

Drug Linked to Diabetic Ketoacidosis, Several Life-Threatening Side Effects DALLAS (Nov. 3, 2015) – The national law firm of Baron & Budd is investigating possible lawsuits involving Invokana, a diabetes drug manufactured by Janssen Pharmaceuticals, [...]

November 3rd, 2015|Pharmaceuticals|